3Struthers A D. Aldosterone escape during angiotensinconverting enzyme inhibitor therapy in chronic heart failure[J].J Card Fa11,1996,2(1) :47-54.
4Pitt B, Zannad F, Remme W J, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators[J]. N Engl J Med,1999,341(10):709-717.
5Kenneth C,Bilchick M D,BarryFetics M S E, et al . Prognostic value of heart rate variability in chronic congestive heart failure(veterans affairs suvival trial of antiarrhythmic therapy in congestive heart failure) [J]. Am J Cardiol,2002,90(1) :24-28.
6Mehmet E K, Haldun M, Melek U, et al. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure [J] . Am J Cardiol, 2000,86 (6) : 649-653.
6Held C,C.erstein HC,YusufS,et al.Glucose levels predict hospitalizationfor congestive heart failure in patients at high cardiovascularrisk.Circulation,2007,115(11):1371-1375.
